pregabalin

Pregabalin

Pregabalin also called Lyrica is an anti-epileptic drug or an anticonvulsant. Pregabalin is available only with your doctor’s prescription. Pregabalin works by slowing down impulses in the brain that cause seizures or epilepsy. Pregabalin also affects chemicals in the brain that send pain signals across the nervous system or damaged nerves in the body. Pregabalin is used to treat pain caused by fibromyalgia (a long-lasting condition that may cause pain, muscle stiffness and tenderness, tiredness, and difficulty falling asleep or staying asleep) or nerve pain (neuropathic pain from damaged nerves) in people with diabetes called diabetic neuropathy that can occur in your arms, hands, fingers, legs, feet, or toes and herpes zoster post-herpetic neuralgia (the burning, stabbing pain or aches that may last for months or years after an attack of shingles), or spinal cord injury. Pregabalin is also used with other medications (adjunctive therapy) to treat partial-onset seizures in adults and children aged at least 1 month of age and older. Pregabalin will not cure epilepsy and will only work to control seizures for as long as you continue to take it.

Pregabalin is available in capsules in varying concentrations from 25 to 300 mg under the brand name of Lyrica, an oral solution (liquid) and as an extended-release (long-acting) tablet to take by mouth. Pregabalin capsules and oral solution are usually taken with or without food two or three times a day. Pregabalin extended-release tablets are usually taken once daily after an evening meal. Take pregabalin at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.

Swallow the extended-release tablets whole; do not cut, chew, or crush them.

Your doctor will probably start you on a low dose of pregabalin and may gradually increase your dose during the first week of treatment.

Take pregabalin exactly as directed. Pregabalin may be habit forming. Do not take a larger dose, take it more often, or take it for a longer period of time than prescribed by your doctor.

Pregabalin may help control your symptoms but will not cure your condition. It may take several weeks or longer before you feel the full benefit of pregabalin. Continue to take pregabalin even if you feel well. Do not stop taking pregabalin without talking to your doctor, even if you experience side effects such as unusual changes in behavior or mood. If you suddenly stop taking pregabalin, you may experience withdrawal symptoms, including trouble falling asleep or staying asleep, nausea, diarrhea, headaches, or seizures. Your doctor will probably decrease your dose gradually over at least 1 week.

Your doctor or pharmacist will give you the manufacturer’s patient information sheet (Medication Guide) when you begin treatment with pregabalin and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the manufacturer’s website to obtain the Medication Guide.

Most reported adverse effects caused by pregabalin were mild to moderate intensity, dose-dependent, and occurred within the first two weeks of initiating treatment. The most common side effects of pregabalin are dose related and include peripheral swelling (edema), weight gain, dizziness, somnolence, confusion, headache, blurred vision, tremor and ataxia 1. The most common adverse reactions reported across all patient populations in premarketing controlled trials, which occurred in greater than or equal to 5% of patients taking pregabalin and twice the rate reported by patients receiving placebo, were: somnolence, dizziness, blurred vision, difficulty with concentration/attention, dry mouth, edema, and weight gain 2, 3. Rare but potentially severe adverse events include depression, suicidal ideation and behaviors, angioedema, and hypersensitivity reactions 4, 5.

Weight gain associated with pregabalin is dose-dependent and occurred in up to 14% of patients receiving 600 mg per day.

Following rapid or abrupt discontinuation of pregabalin, some patients reported symptoms including insomnia, nausea, headache, anxiety, nervousness, irritability, hyperhidrosis, and diarrhea 1.

Chronic use of pregabalin can result in physical dependence, and there is a risk of abuse associated with its use, especially in patients on opioid medicines or who have a history of substance abuse 6.

Pregabalin special precautions

Pregabalin Warnings

Pregabalin can cause a severe allergic reaction. Stop taking pregabalin and seek emergency medical help if you have hives or blisters on your skin, trouble breathing, or swelling in your face, mouth, or throat.

Some people have thoughts about suicide while taking pregabalin. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.

If you have diabetes or heart problems, call your doctor if you have weight gain or swelling in your hands or feet while taking pregabalin.

Do not stop using pregabalin suddenly, even if you feel fine. Stopping suddenly may cause withdrawal symptoms.

Before taking pregabalin:

  • tell your doctor and pharmacist if you are allergic to pregabalin, any other medications, or any of the ingredients in pregabalin preparations. Ask your pharmacist for a list of the ingredients.
  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: angiotensin converting enzyme (ACE) inhibitors such as benazepril (Lotensin, in Lotrel), captopril (Capoten, in Capozide), enalapril (Vasotec, in Vaseretic, Lexxel), fosinopril (Monopril), lisinopril (Prinivil, Zestril, in Prinzide, Zestoretic), moexipril (Univasc, in Uniretic), perindopril (Aceon), quinapril (Accupril, in Accuretic, Quinaretic), ramipril (Altace), and trandolapril (Mavik, in Tarka); antidepressants; antihistamines; medications for anxiety including lorazepam (Ativan); medications for mental illness or seizures; certain medications for diabetes such as pioglitazone (Actos, in Duetact) and rosiglitazone (Avandia, in Avandaryl, Avandamet); opioid (narcotic) pain medications including hydrocodone (in Hydrocet, in Vicodin, others), morphine (Avinza, Kadian, MSIR, others), or oxycodone (OxyContin, in Percocet, others); sedatives; sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • tell your doctor if you drink or have ever drunk large amounts of alcohol, use or have ever used street drugs, or have overused prescription medications. Also tell your doctor if you have or have ever had swelling of the eyes, face, lips, tongue, or throat; vision problems; heart failure; bleeding problems or a low number of platelets (type of blood cell needed for blood clotting) in your blood, or lung, heart, or kidney disease.
  • tell your doctor if you are pregnant or if you or your partner plans to become pregnant. Also tell your doctor if you are breastfeeding. If you or your partner becomes pregnant while you are taking pregabalin, call your doctor. Pregabalin has caused decreased fertility in male animals and birth defects in the offspring of male and female animals who were treated with the medication. There is not enough information to tell if pregabalin causes these problems in humans.
  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking pregabalin.
  • you should know that pregabalin may make you dizzy or drowsy. Do not drive a car operate machinery, or do other dangerous activities until you know how this medication affects you. Ask your doctor when you may do these activities.
  • do not drink alcohol while taking pregabalin. Alcohol can add to the drowsiness caused by this medication.
  • you should know that your mental health may change in unexpected ways and you may become suicidal (thinking about harming or killing yourself or planning or trying to do so) while you are taking pregabalin for the treatment of epilepsy, mental illness, or other conditions. A small number of adults and children 5 years of age and older (about 1 in 500 people) who took anticonvulsants such as pregabalin to treat various conditions during clinical studies became suicidal during their treatment. Some of these people developed suicidal thoughts and behavior as early as 1 week after they started taking the medication. There is a risk that you may experience changes in your mental health if you take an anticonvulsant medication such as pregabalin, but there may also be a risk that you will experience changes in your mental health if your condition is not treated. You and your doctor will decide whether the risks of taking an anticonvulsant medication are greater than the risks of not taking the medication. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: panic attacks; agitation or restlessness; new or worsening irritability, anxiety, or depression; acting on dangerous impulses; difficulty falling or staying asleep; aggressive, angry, or violent behavior; mania (frenzied, abnormally excited mood); talking or thinking about wanting to hurt yourself or end your life; withdrawing from friends and family; preoccupation with death and dying; giving away prized possessions; or any other unusual changes in behavior or mood. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to pregabalin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Kidney impaired patients

Pregabalin is eliminated primarily by kidney excretion. Adjust the dose in patients with impaired kidney function. According to drug manufacturers the following are recommendations on dose reductions for patients with reduced creatinine clearance (CrCl) and those undergoing hemodialysis.

  • Creatinine clearance (CrCl) greater than or equal to 60 mL/min- no dose modification recommended
  • Creatinine clearance (CrCl) 30 – 60 mL/min – 50% dose of recommended daily dose
  • Creatinine clearance (CrCl) 15- 30 mL/min – 25% dose of recommended daily dose
  • Creatinine clearance (CrCl) less than or equal to 15 mL/min – 16% to 8% dose of recommended daily dose
  • Supplementary dosage of approximately an additional 25 mg of recommended daily dose following hemodialysis is recommended

Children

Appropriate studies have not been performed on the relationship of age to the effects of pregabalin in children younger than 1 month of age for partial onset seizures. Safety and efficacy have not been established for other conditions.

Breastfeeding women

Pregabalin has been detected in the milk of lactating women; thus, breastfeeding is not advisable, and an alternative agent is preferred 7. There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking Pregabalin while breastfeeding.

Pregnancy

Pregabalin may cause fetal harm. Advise patients there is a potential risk to the fetus 8. To monitor pregnancy outcomes in women exposed to pregabalin during pregnancy and provide information on the effects of in utero exposure to pregabalin, clinicians should help enroll pregnant patients in the North American Antiepileptic Drug Pregnancy Registry (https://www.aedpregnancyregistry.org).

Liver Impairment

Although not explicitly studied, because pregabalin is not protein-bound, it is unlikely that patients with hepatic impairment require dosing modifications.

Elderly patients

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of pregabalin in the elderly. However, elderly patients are more likely to have unwanted effects (eg, dizziness, blurred vision, confusion, or clumsiness) and age-related kidney problems, which may require an adjustment in the dose for patients receiving pregabalin.

Drug Interactions

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking pregabalin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using pregabalin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

  • Acepromazine
  • Alfentanil
  • Alprazolam
  • Amobarbital
  • Anileridine
  • Aripiprazole
  • Asenapine
  • Baclofen
  • Benperidol
  • Benzhydrocodone
  • Bromazepam
  • Buprenorphine
  • Buspirone
  • Butabarbital
  • Butorphanol
  • Calcifediol
  • Calcium Oxybate
  • Cannabidiol
  • Carbinoxamine
  • Carisoprodol
  • Carphenazine
  • Chloral Hydrate
  • Chlordiazepoxide
  • Chlorpromazine
  • Chlorzoxazone
  • Clobazam
  • Clonazepam
  • Clorazepate
  • Clozapine
  • Codeine
  • Cyclobenzaprine
  • Dexmedetomidine
  • Diacetylmorphine
  • Diazepam
  • Dichloralphenazone
  • Difenoxin
  • Dihydrocodeine
  • Diphenhydramine
  • Diphenoxylate
  • Doxylamine
  • Droperidol
  • Enflurane
  • Esketamine
  • Estazolam
  • Eszopiclone
  • Ethchlorvynol
  • Ethopropazine
  • Ethylmorphine
  • Fentanyl
  • Flibanserin
  • Fluphenazine
  • Flurazepam
  • Fluspirilene
  • Fospropofol
  • Gabapentin
  • Gabapentin Enacarbil
  • Halazepam
  • Haloperidol
  • Halothane
  • Hexobarbital
  • Hydrocodone
  • Hydromorphone
  • Hydroxyzine
  • Isoflurane
  • Ketamine
  • Ketazolam
  • Ketobemidone
  • Levorphanol
  • Lorazepam
  • Loxapine
  • Magnesium Oxybate
  • Meclizine
  • Melperone
  • Meperidine
  • Mephobarbital
  • Meprobamate
  • Meptazinol
  • Mesoridazine
  • Metaxalone
  • Methadone
  • Methdilazine
  • Methocarbamol
  • Methohexital
  • Methotrimeprazine
  • Methylene Blue
  • Midazolam
  • Molindone
  • Moricizine
  • Morphine
  • Morphine Sulfate Liposome
  • Nalbuphine
  • Nicomorphine
  • Nitrazepam
  • Nitrous Oxide
  • Olanzapine
  • Opium
  • Opium Alkaloids
  • Orlistat
  • Orphenadrine
  • Oxazepam
  • Oxycodone
  • Oxymorphone
  • Papaveretum
  • Paregoric
  • Pentazocine
  • Pentobarbital
  • Perampanel
  • Perazine
  • Periciazine
  • Perphenazine
  • Phenobarbital
  • Pimozide
  • Piperacetazine
  • Pipotiazine
  • Piritramide
  • Potassium Oxybate
  • Prazepam
  • Primidone
  • Prochlorperazine
  • Promazine
  • Promethazine
  • Propofol
  • Quazepam
  • Quetiapine
  • Ramelteon
  • Remifentanil
  • Remimazolam
  • Remoxipride
  • Secobarbital
  • Sertindole
  • Sodium Oxybate
  • Sufentanil
  • Sulpiride
  • Suvorexant
  • Tapentadol
  • Temazepam
  • Thiethylperazine
  • Thiopental
  • Thiopropazate
  • Thioridazine
  • Tilidine
  • Tizanidine
  • Tolonium Chloride
  • Topiramate
  • Tramadol
  • Triazolam
  • Trifluoperazine
  • Trifluperidol
  • Triflupromazine
  • Trimeprazine
  • Zaleplon
  • Zolpidem
  • Zopiclone
  • Zotepine

Other Interactions

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of pregabalin. Make sure you tell your doctor if you have any other medical problems, especially:

  • Alcohol or drug abuse, history of or
  • Angioedema (severe swelling), history of or
  • Congestive heart failure or
  • Diabetes: May cause side effects to become worse.
  • Behavior changes, history of or
  • Bleeding disorder or
  • Depression, history of or
  • Edema (body swelling or fluid retention) or
  • Heart rhythm problem (eg, prolonged PR interval) or
  • Lung or breathing problems (eg, respiratory depression) or
  • Thrombocytopenia (low platelets in the blood): Use with caution. May make these conditions worse.
  • Kidney disease: Use with caution. The effects may be increased because of slower removal of the medicine from the body.

How does pregabalin work?

Pregabalin is an alkylated analogue of gamma-aminobutyric acid (GABA) and is structurally related to gabapentin. However, pregabalin does not directly bind to GABA-A or GABA-B receptors 9. Additionally, Pregabalin is not metabolized to a GABA receptor agonist. In animal models, pregabalin binds to presynaptic voltage-gated calcium channels at the alpha-2-delta subunit in central nervous system tissues. The binding of the alpha-2-delta subunit decreases the depolarization-induced influx of calcium into neurons and reduces the release of excitatory neurotransmitters by hyperexcited neurons 10, 11, 12. This action may account for the anticonvulsant and analgesic effects of pregabalin. Pregabalin has no known activity at sodium channels, dopamine receptors, serotonin receptors, opiate receptors and does not modify cyclooxygenase activity 13.

Pregabalin has antiepileptic, analgesic, and anxiolytic effects. Pregabalin has been shown to be effective in reducing neuropathic pain from diabetic and postherpetic neuropathy and is an effective anticonvulsant 12.

Pregabalin works in different ways:

  • In epilepsy Pregabalin stops seizures by reducing the abnormal electrical activity in your brain
  • With nerve pain Pregabalin blocks pain by affecting the pain messages traveling through your brain and down your spinal cord
  • In anxiety Pregabalin stops your brain from releasing the chemicals that make you feel anxious.

Pregabalin uses

Pregabalin was approved for use in the United States in 2004 to treat epilepsy and anxiety. Pregabalin is an anticonvulsant and neuropathic pain agent. Pregabalin works in the central nervous system (CNS) to control seizures and pain. Pregabalin is used with other medicines to help control partial-onset seizures (convulsions) in the treatment of epilepsy in patients 1 month of age and older. Pregabalin will not cure epilepsy and will only work to control seizures for as long as you continue to take it.

Pregabalin United States Food and Drug Administration (FDA)-approved indications 14, 1, 15, 16:

  • Treatment of nerve pain or neuropathic pain associated with diabetic peripheral neuropathy (diabetic neuropathy or pain caused by nerve damage from diabetes)
  • Treatment of nerve pain or neuropathic pain associated with spinal cord injury
  • Neuropathic pain originating from postherpetic neuralgia (nerve pain that occurs after shingles)
  • Treatment of fibromyalgia (muscle pain and stiffness).
  • Adjunctive therapy for partial-onset seizures in adults with epilepsy

Pregabalin Off-label Uses 17, 18, 19:

  • Generalized anxiety disorder
  • Social anxiety disorder
  • Bipolar disorder
  • Insomnia
  • Chronic pain conditions
  • Chronic Pruritus (chronic itch)
  • Chronic cough
  • Migraine
  • Restless leg syndrome

There is significant disagreement regarding the effectiveness of pregabalin for the psychiatric disorders listed above. Therefore, prescribers should be careful and monitor patients for therapeutic success when treating patients with pregabalin 9.

Pregabalin dosage

Pregabalin is only available on prescription. It comes as capsules, tablets (extended release) or a liquid that you swallow. Take Ppregabalin exactly as prescribed by your doctor and read all medication guides or instruction sheets about pregabalin. Your doctor may occasionally change your dose. Pregabalin recommended initial dose for neuropathic pain is 50 to 75 mg two to three times daily, the maximum dose being 300 mg daily. Higher doses are used in treating seizures. The dose should be increased and tapered gradually.

Take pregabalin exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. To do so may increase the chance of side effects.

Pregabalin capsule or oral liquid may be taken with or without food.

Take the extended-release tablet after an evening meal. Swallow it whole. Do not crush, break, or chew it.

Measure the oral liquid using a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid.

Call your doctor if your symptoms do not improve, or if they get worse.

Do not stop using pregabalin suddenly, even if you feel fine. Stopping suddenly may cause increased seizures or unpleasant withdrawal symptoms. Follow your doctor’s instructions about tapering your dose for at least 1 week before stopping completely.

In case of emergency, wear or carry medical identification to let others know you take seizure medication.

Store at room temperature away from moisture, heat, and light.

The dose of pregabalin will be different for different patients. Follow your doctor’s orders or the directions on the label. The following information includes only the average doses of pregabalin. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

Diabetic nerve pain

For oral dosage forms (capsules and solution):

  • Adults: At first, 50 milligrams (mg) 3 times a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 300 mg per day (maximum therapeutic dose is 300 mg/day). The dose can increase up to 300 mg/day within one week of starting treatment 14.
  • Children: Use and dose must be determined by your doctor.

For oral dosage forms (extended-release tablets):

  • Adults: At first, 165 milligrams (mg) once a day for 1 week. Your doctor may increase your dose as needed and tolerated. However, the dose is usually not more than 330 mg per day.
  • Children: Use and dose must be determined by your doctor.

Partial-onset seizures

For oral dosage forms (capsules and solution):

  • Adults and children 17 years of age and older: At first, 150 milligrams (mg) per day given in 2 or 3 divided doses. Your doctor may adjust your dose as needed. However, the dose is usually not more than 600 mg per day. The effective dose is 150 mg to 600 mg per day, divided 2 or 3 times per dosing. The suggested starting dose is no greater than 150 mg per day. The total dose can increase to a maximum of 600 mg per day.
  • Children 1 month of age and older weighing 30 kilograms (kg) or more: Use is based on body weight and must be determined by your doctor. The usual dose is 2.5 milligram per kilogram (mg/kg) per day given in 2 or 3 divided doses. Your doctor may adjust your dose as needed. However, the dose is usually not more than 10 mg/kg (600 mg) per day.
  • Children 1 month of age and older weighing less than 30 kilograms (kg): Use is based on body weight and must be determined by your doctor. The usual dose is 3.5 milligram per kilogram (mg/kg) per day given in 3 divided doses. Your doctor may adjust your dose as needed. However, the dose is usually not more than 14 mg/kg per day.
  • Children younger than 1 month of age: Use and dose must be determined by your doctor.

Fibromyalgia

For oral dosage forms (capsules and solution):

  • Adults: At first, 75 milligrams (mg) 2 times a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 450 mg per day. The recommended therapeutic dose is 300 mg to 450 mg per day. The recommended starting dose is 150 mg/day divided into twice per day dosing. The dose can increase to 300 mg per day within one week of starting treatment. Patients with suboptimal pain relief on 300 mg per day may further increase to 450 mg per day, divided into twice per day dosing.
  • Children: Use and dose must be determined by your doctor.

Post-herpetic neuralgia

For oral dosage forms (capsules and solution):

  • Adults: At first, 75 to 150 milligrams (mg) 2 times a day, or 50 to 100 mg 3 times a day. Your doctor may adjust your dose as needed and tolerated. However, the dose is usually not more than 600 mg per day. The recommended therapeutic dose is 150 mg to 300 mg per day, divided into dosing 2 or 3 times per day. The recommended starting dose is 75 mg two times per day or 50 mg three times per day. The dose can increase up to 300 mg per day within one week of starting treatment. After 2 to 4 weeks of treatment with 300 mg per day, patients with suboptimal pain relief can be increased to 600 mg per day, divided into twice per day or three times per dosing.
  • Children: Use and dose must be determined by your doctor.

For oral dosage forms (extended-release tablets):

  • Adults: At first, 165 milligrams (mg) once a day for 1 week. Your doctor may increase your dose to 330 mg as needed and tolerated. However, the dose is usually not more than 660 mg per day.
  • Children: Use and dose must be determined by your doctor.

Spinal cord injury nerve pain

For oral dosage forms (capsules and solution):

  • Adults: At first, 75 milligrams (mg) 2 times a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 600 mg per day. The dose may be increased to 150 mg twice per day within one week of initiating treatment. Patients with suboptimal pain relief following 2 to 3 weeks of treatment with 150 mg twice a day may be increased up to 300 mg twice per day. In spinal cord injury, pain improvement can be seen as early as one week after initiating treatment. However, to evaluate the efficacy of pregabalin, it is recommended to try the medication for 4 to 6 weeks if tolerated by the patient 20.
  • Children: Use and dose must be determined by your doctor.

Refractory Chronic Cough

Pregabalin is off-label used in refractory chronic cough conditions. The initial starting dose is 75 mg per day, which may increase by 75 mg per day during the first week of treatment. The maximum dose can be up to 300 mg per day, divided into three times per dosing 21.

Generalized Anxiety Disorder (GAD)

Pregabalin is also off-label used in generalized anxiety disorder. The initial starting dose is 75 mg per day, which may increase by 75 mg per day during the first week of treatment. The maximum dose can be up to 300 mg per day, divided into three times per dosing 22.

Social Anxiety Disorder (SAD)

Pregabalin is off-label used as mono or adjuvant therapy in social anxiety disorder, cough, and chronic refractory conditions. The initial starting dose is 100 mg three times a day, which may increase by 150 mg per day over one week. This dose may go up to 600 mg daily based on response and tolerability 23.

Chronic Pruritus (Chronic Itch)

Pregabalin is also off-label used as a preferred treatment in patients with brachioradial pruritus, a rare type of chronic pruritus that usually localized at the dorsolateral part of the forearms. Itching, burning, or pain are common symptoms at the involved areas. The causal factors are still unknown but sun exposure and/or cervical spine lesions seem to be trigerring or precipiting factors 24. Neuropathogenic mechanism plays role in etiopathogenesis of brachioradial pruritus, therefore, antiepileptic drugs such as gabapentin, oxcarbazepine. and pregabalin are suggested medications for BRP. Herein, we report three cases with brachioradial pruritus successfully treated with pregabaline. The initial starting dose is 75 mg twice daily, which may increase by 150 mg to 300 mg in two to three divided doses daily. This dose may go up to 600 mg daily in oncology patient populations 24.

Restless Legs Syndrome

Another off-label use of pregabalin is in restless legs syndrome. The initial starting dose is 50 mg to 75 mg daily before bedtime, which may increase by 75 mg to 150 mg every week. The usual therapeutic dose is up to 150 mg to 450 mg daily based on the effectiveness and tolerability of therapy 25.

What should I do if I forget a dose?

If you are taking pregabalin capsules or the oral solution and forget to take a dose and remember a few hours later, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

If you are taking pregabalin extended-release tablets and forget to take a dose after your evening meal, take the missed dose before bedtime after a snack. If you miss taking the dose prior to bedtime, take your dose the following day after breakfast. If you miss taking the dose after breakfast, take your dose at the usual time after an evening meal and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Pregabalin side effects

Pregabalin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • tiredness
  • dizziness
  • headache
  • dry mouth
  • nausea
  • vomiting
  • constipation
  • gas
  • bloating
  • ”high” or elevated mood
  • speech problems
  • difficulty concentrating or paying attention
  • difficulty remembering or forgetfulness
  • anxiety
  • lack of coordination
  • loss of balance or unsteadiness
  • uncontrollable shaking or jerking of a part of the body
  • muscle twitching
  • weakness
  • increased appetite
  • weight gain
  • back pain

Some side effects can be serious. If you experience any of these symptoms, see your doctor immediately:

  • blurred vision, double vision, or other changes in eyesight
  • hives
  • rash
  • itching
  • blisters
  • swelling of the eyes, face, throat, mouth, lips, gums, tongue, head or neck
  • swelling of the arms, hands, feet, ankles, or lower legs
  • shortness of breath
  • wheezing
  • muscle pain, tenderness, soreness, or weakness, especially if it comes along with fever
  • chest pain
  • difficulty breathing; bluish-tinged skin, lips, or fingernails; confusion; or extreme sleepiness

If you have diabetes, you should know that pregabalin has caused skin sores in animals. Pay extra attention to your skin while taking pregabalin, and tell your doctor if you have any sores, redness, or skin problems.

Pregabalin may cause other side effects. Call your doctor if you have any unusual problems while taking pregabalin.

Pregabalin overdose

There is limited information regarding overdose with pregabalin. The highest known accidental overdose of pregabalin during clinical development was 8000 mg; this event was without significant clinical consequences. There is no specific antidote for overdose with pregabalin.

The most commonly reported adverse events with overdose were reduced consciousness, confusional state, agitation, depression/anxiety, and restlessness in the postmarketing studies. In addition, heart block, seizures, and death have also been reported in some patients taking combination with other central nervous system depressants 26.

Pregabalin overdose treatment

  • If required, elimination of unabsorbed drugs can be performed by gastric lavage or emesis. General supportive care should be provided to the patient. Maintain airway and monitor vital signs and clinical status of the patient. Contact a Certified Poison Control Center (https://poisonhelp.hrsa.gov/poison-centers/find-poison-center) for up-to-date information on the management of overdose with pregabalin. The national, toll-free Poison Help line, 1-800-222-1222, connects you to your local poison center and is your resource for help in a poisoning emergency. You can call from anywhere in the United States and many territories.
  • Pregabalin can be removed by standard hemodialysis procedures, resulting in approximately 50% clearance of pregabalin in 4 hours.

Pregabalin Contraindications

Pregabalin is contraindicated in patients who have a known hypersensitivity to pregabalin. Hypersensitivity reactions have occurred in patients receiving pregabalin, including angioedema 5. There are no adequate studies with pregabalin in pregnant women. Pregabalin may cause fetal harm. Advise patients there is a potential risk to the fetus 8. Pregabalin has been detected in the milk of lactating women; thus, breastfeeding is not advisable, and an alternative agent is preferred 7. There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking Pregabalin while breastfeeding.

  1. Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007076. doi: 10.1002/14651858.CD007076.pub3[][][]
  2. Drugs for chronic insomnia. Med Lett Drugs Ther. 2018 Dec 17;60(1562):201-205. https://secure.medicalletter.org/TML-article-1562a[]
  3. Preuss CV, Kalava A, King KC. Prescription of Controlled Substances: Benefits and Risks. [Updated 2023 Apr 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537318[]
  4. Abrahamsson T, Berge J, Öjehagen A, Håkansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study. Drug Alcohol Depend. 2017 May 1;174:58-64. doi: 10.1016/j.drugalcdep.2017.01.013[]
  5. Ortega-Camarero MA, Avila R, Prados Castaño M, Piñero M, Quiralte J, Cimbollek S. Challenge-based pregabalin induced urticaria and angioedema. A case report. Allergol Immunopathol (Madr). 2012 Sep-Oct;40(5):323. doi: 10.1016/j.aller.2011.09.012[][]
  6. Chalabianloo F, Schjøtt J. Pregabalin og misbrukspotensial [Pregabalin and its potential for abuse]. Tidsskr Nor Laegeforen. 2009 Jan 29;129(3):186-7. Norwegian. doi: 10.4045/tidsskr.08.0047[]
  7. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Pregabalin. [Updated 2023 Jul 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501821[][]
  8. Andrade C. Safety of Pregabalin in Pregnancy. J Clin Psychiatry. 2018 Oct 2;79(5):18f12568. doi: 10.4088/JCP.18f12568[][]
  9. Cross AL, Viswanath O, Sherman Al. Pregabalin. [Updated 2022 Nov 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470341[][]
  10. Patel R, Dickenson AH. Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain. Pharmacol Res Perspect. 2016 Feb 27;4(2):e00205. doi: 10.1002/prp2.205[]
  11. de Guglielmo G, Cippitelli A, Somaini L, Gerra G, Li H, Stopponi S, Ubaldi M, Kallupi M, Ciccocioppo R. Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat. Addict Biol. 2013 Jul;18(4):644-53. doi: 10.1111/j.1369-1600.2012.00468.x[]
  12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Pregabalin. [Updated 2020 Jul 30]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548053[][]
  13. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007 Feb;73(2):137-50. doi: 10.1016/j.eplepsyres.2006.09.008[]
  14. Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, Furlan A, Gilron I, Gordon A, Morley-Forster PK, Sessle BJ, Squire P, Stinson J, Taenzer P, Velly A, Ware MA, Weinberg EL, Williamson OD; Canadian Pain Society. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014 Nov-Dec;19(6):328-35. doi: 10.1155/2014/754693[][]
  15. Bidari A, Moazen-Zadeh E, Ghavidel-Parsa B, Rahmani S, Hosseini S, Hassankhani A. Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial. Daru. 2019 Jun;27(1):149-158. doi: 10.1007/s40199-019-00257-4[]
  16. Abou-Khalil BW. Update on Antiepileptic Drugs 2019. Continuum (Minneap Minn). 2019 Apr;25(2):508-536. doi: 10.1212/CON.0000000000000715[]
  17. Goodman CW, Brett AS. A Clinical Overview of Off-label Use of Gabapentinoid Drugs. JAMA Intern Med. 2019 May 1;179(5):695-701. doi: 10.1001/jamainternmed.2019.0086[]
  18. Parikh SK, Silberstein SD. Current Status of Antiepileptic Drugs as Preventive Migraine Therapy. Curr Treat Options Neurol. 2019 Mar 18;21(4):16. doi: 10.1007/s11940-019-0558-1[]
  19. Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, Eide PK, Leal PRL, Maarbjerg S, May A, Nurmikko T, Obermann M, Jensen TS, Cruccu G. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019 Jun;26(6):831-849. doi: 10.1111/ene.13950[]
  20. Davari M, Amani B, Amani B, Khanijahani A, Akbarzadeh A, Shabestan R. Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis. Korean J Pain. 2020 Jan 1;33(1):3-12. doi: 10.3344/kjp.2020.33.1.3[]
  21. Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough: A Randomized Controlled Trial. Chest. 2016 Mar;149(3):639-48. doi: 10.1378/chest.15-1271[]
  22. Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ. 2011 Mar 11;342:d1199. doi: 10.1136/bmj.d1199[]
  23. Feltner DE, Liu-Dumaw M, Schweizer E, Bielski R. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study. Int Clin Psychopharmacol. 2011 Jul;26(4):213-20. doi: 10.1097/YIC.0b013e32834519bd[]
  24. Atış G, Bilir Kaya B. Pregabalin treatment of three cases with brachioradial pruritus. Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12459[][]
  25. Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW. Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med. 2014 Feb 13;370(7):621-31. doi: 10.1056/NEJMoa1303646[]
  26. Evoy KE, Morrison MD, Saklad SR. Abuse and Misuse of Pregabalin and Gabapentin. Drugs. 2017 Mar;77(4):403-426. doi: 10.1007/s40265-017-0700-x[]
Health Jade